DEC 06, 2018 6:00 AM CET

Overview of the main hormones associated with alteration of bone and mineral metabolism in patients with chronic kidney disease

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Ex head of Laboratoire d'explorations fonctionnelles hôpital Necker-Enfants malades
    Biography
      Now retired (but still active), JCS was the chief of the hormone laboratory in the department of Physiology of the University Necker-Enfants malades hospital in Paris, France, and an invited professor at the Liège University, Belgium. Its main research/clinical topics were the growth hormone/IGFI axis and all aspects of bone and mineral metabolism. He also focused on the importance of vitamin D in many disease other than bone and mineral diseases. He has published more than 300 papers in peer-reviewed journal that are referenced in Pubmed. He was an active member of the scientific committee of the French group of research and information on osteoporosis (GRIO) and a member of the editorial board of several journals.

    Abstract
    DATE: December 6, 2018
    TIME:  6:00am PST, 9:00am EST, 3:00pm CET
     
    Alterations in the bone and mineral metabolism is of great concern in patients with chronic kidney disease (CKD). As the glomerular filtration rate (GFR) decreases, phosphatemia tends to increase while the renal secretion of the active vitamin D metabolite decreases with, consequently, increases in both serum PTH and FGF23 levels. This the pathophysiological basis of the so-called CKD-bone and mineral disorders (MBD). Experts in Nephrology have published international guidelines, called the KDIGO/CKD-MBD, to help the colleagues to deal with these disorders. In this webinar, the KDIGO recommendations concerning the measurement of the serum concentration of PTH, vitamin D metabolites and FGF23 will be discussed.
     
    Learning Objective:
    • Understand the bone metabolic disorder in CKD patients
    • Which is the mechanism that regulate the calcium and phosphorus absorption in patient with altered hormone activities
    • Know the utility of a few fundamental markers to decide the CKD patient management

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources
    Attendees
    • See more